Veradigm | MDRX - Sales Revenues


Veradigm reported $142.52M in Sales Revenues for its fiscal quarter ending in December of 2022.





Sales Change Date
Alcidion AUD 25.47M 2.32M Dec/2025
Ambu A/S DKK 1.56B 90M Dec/2025
Amplifon EUR 652M 88.7M Dec/2025
Cardinal Health USD 65.63B 1.63B Dec/2025
Centene USD 49.73B 40M Dec/2025
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Cigna USD 72.47B 2.77B Dec/2025
Coloplast 7.04B 83M Dec/2025
Computer Programs Systems USD 87.79M 3.96M Dec/2025
Convatec Group USD 1.26B 80M Dec/2025
CVS Health USD 105.7B 2.8B Dec/2025
Diasorin EUR 295M 15M Dec/2025
Elevance Health USD 49.5B 200M Mar/2026
General Electric Aerospace USD 11.6B 270M Mar/2026
Gulf Medical Proj AED 213.77M 25.43M Dec/2025
Humana USD 32.52B 130M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Laboratory Of America USD 3.52B 40M Dec/2025
Maximus USD 1.35B 30M Dec/2025
McKesson USD 106.16B 3.01B Dec/2025
Med Life RON 787.96M 8.36M Sep/2025
Molina Healthcare USD 10.8B 580M Mar/2026
Omnicell USD 314M 3.37M Dec/2025
Oriola-kd EUR 502M 38.7M Dec/2025
Owens Minor USD 708.97M 11.71M Dec/2025
Quest Diagnostics USD 2.9B 90M Mar/2026
Rede D'or Sao Luiz BRL 14.38B 220M Dec/2025
Siemens Healthineers EUR 5.4B 920M Dec/2025
Sonova Holding CHF 1.82B 216.8M Dec/2025
Supermax Corporation Bhd MYR 187.44M 18.13M Dec/2025
UnitedHealth USD 111.7B 1.5B Mar/2026
Veeva Systems USD 835.95M 24.72M Dec/2025
Veradigm USD 142.52M 9.38M Dec/2022
Xerox USD 2.03B 70M Dec/2025